These findings identify CDC20 as a potential biomarker for SAC inhibitor sensitivity. Analysis of 1,700 human cancer cell lines combined with a CRISPR-Cas9 screen under MPS1 inhibition conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback